The factorial MR analysis observed no clear evidence for interactions between Lp(a) lowering and LDL-C lowering or lifestyle improvements in CVD risk reduction, except for the PAD outcome when combining low-level Lp(a) with low-level LDL-C. The gene discussed is LPA; the disease is peripheral arterial disease.